These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30758660)

  • 1. FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation.
    de Ridder M; Gouw ZAR; Navran A; Hamming-Vrieze O; Jasperse B; van den Brekel MWM; Vogel WV; Al-Mamgani A
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1447-1455. PubMed ID: 30758660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
    Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
    Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
    Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using
    Greuter MJ; Schouten CS; Castelijns JA; de Graaf P; Comans EF; Hoekstra OS; de Bree R; Coupé VM
    BMC Cancer; 2017 Apr; 17(1):256. PubMed ID: 28399836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
    Helsen N; Roothans D; Van Den Heuvel B; Van den Wyngaert T; Van den Weyngaert D; Carp L; Stroobants S
    PLoS One; 2017; 12(8):e0182350. PubMed ID: 28771540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.
    Vainshtein JM; Spector ME; Stenmark MH; Bradford CR; Wolf GT; Worden FP; Chepeha DB; McHugh JB; Carey T; Wong KK; Eisbruch A
    Oral Oncol; 2014 Mar; 50(3):234-9. PubMed ID: 24387978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
    Prestwich RJ; Subesinghe M; Gilbert A; Chowdhury FU; Sen M; Scarsbrook AF
    Clin Radiol; 2012 Oct; 67(10):966-75. PubMed ID: 22595082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V
    J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
    Urban R; Godoy T; Olson R; Wu J; Berthelet E; Tran E; DeVries K; Wilson D; Hamilton S
    Radiother Oncol; 2020 Jul; 148():14-20. PubMed ID: 32294581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
    Bird T; Barrington S; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1239-47. PubMed ID: 26707387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
    Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection.
    Navran A; Kayembe MT; Gouw ZAR; Vogel WV; Karssemakers L; Paul de Boer J; Donswijk ML; Schreuder WH; Owers E; van den Brekel M; Al-Mamgani A
    Radiother Oncol; 2024 Sep; 198():110407. PubMed ID: 38942119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
    Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
    Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
    Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
    Chen AY; Vilaseca I; Hudgins PA; Schuster D; Halkar R
    Head Neck; 2006 Jun; 28(6):487-95. PubMed ID: 16619274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
    Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
    Zhong J; Sundersingh M; Dyker K; Currie S; Vaidyanathan S; Prestwich R; Scarsbrook A
    Sci Rep; 2020 Mar; 10(1):4086. PubMed ID: 32139722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.